Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Harta Djaya Karya Tbk. (MEJA) Price & Performance

UBC Medical Indonesia Tbk.Trade
Harta Djaya Karya Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Harta Djaya Karya Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp168 (market cap 651.75B, 848.2K 24h volume), while Harta Djaya Karya Tbk. trades at Rp120 (market cap 294.71B, 50.13M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.2× Harta Djaya Karya Tbk.'s market cap, and Harta Djaya Karya Tbk. is more actively traded (50.13M versus 848.2K). Which is the better fit depends on your goals.

LABSMEJA
Market Cap
651.75B294.71B
Volume
848.2K50.13M
Lot
8.48K501.34K
Turnover
140.51M5.83B
Average Price
165.66116.29
Value
140.51M5.83B
Indicative Equilibrium Price
168120
Indicative Equilibrium Volume
5013.98K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
MEJA
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Harta Djaya Karya Tbk.

PT Harta Djaya Karya Tbk (the Entity) was established based on the Notarial Deed of Musa Muamarta., S.H., No. 27, dated November 22, 2012. The entity began commercial operations in 2012.

Read more on MEJA